Company Profiles

driven by the PitchBook Platform

SI-BONE

SI-BONE
2008 FOUNDED
PRIVATE STATUS
201-300 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$25.4M LATEST DEAL AMOUNT
8 INVESTORS
Description

Developer of surgical instruments. The company develops minimally invasive surgical devices for fracture fixation of long bones and large bone fragments of the pelvis for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Primary Office
3055 Olin Avenue
Suite 2200
San Jose, CA 95128
United States

+1 (408) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SI-BONE’s full profile, request a free trial.

SI-BONE Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 21-Feb-2017 $25.4M 00000 00000 Completed Generating Revenue
8. Debt - General 18-Nov-2015 000.00 00000 Completed Generating Revenue
7. Later Stage VC 15-Apr-2015 0000 000.00 00000 Completed Generating Revenue
6. Later Stage VC 28-Apr-2014 000.00 000.00 00000 Completed Generating Revenue
5. Early Stage VC 26-Sep-2011 0000 000.00 000.00 Completed Startup
4. Early Stage VC 17-Aug-2010 0000 000.00 000.00 Completed Startup
3. Angel (individual) 15-Dec-2009 00.000 00.000 000.00 Completed Startup
2. Angel (individual) 26-Mar-2009 $1.52M $1.67M 00.000 Completed Startup
1. Angel (individual) 31-Mar-2008 $154K $154K 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

SI-BONE Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series 7 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series 6 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series 5 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series 4 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series 3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series 2 12,773,107 $0.000100 $0.01 $0.12 $0.12 1x $0.12 4.45%
Series 1 4,411,731 $0.000100 $0 $0.03 $0.03 1x $0.03 1.54%
To view this company’s complete Cap Table, request access »

SI-BONE Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Arboretum Ventures Venture Capital Minority 000 0000 000000 0
Redline Capital Management Venture Capital Minority 000 0000 000000 0
Shea Ventures Corporate Venture Capital Minority 000 0000 000000 0
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
OrbiMed Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

SI-BONE Executive Team (18)

Name Title Board
Seat
Contact
Info
Laura Francis Chief Financial Officer
Scott Yerby Ph.D Vice President & Chief Technology Officer
Richard Moss Director & General Manager of United Kingdom & Ireland
Eric Schaber General Manager
Mike Pisetsky JD Vice President, General Counsel & Chief Compliance Officer

1 Former Executive

You’re viewing 5 of 18 executives. Get the full list »

SI-BONE Board Members (12)

Name Representing Role Since Contact
Info
David Bonita MD OrbiMed Board Member 000 0000
Gregory Hinckley Self Board Member 000 0000
Jeffrey Dunn SI-BONE President, Co-Founder, Board Member & Chief Executive Officer 000 0000
Jessica Hou Montreux Equity Partners Board Observer 000 0000
John Freund MD Skyline Ventures Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com